ROLE OF NITRIC-OXIDE IN THE INVITRO SPLANCHNIC VASCULAR HYPOREACTIVITY IN ASCITIC CIRRHOTIC RATS

被引:183
|
作者
SIEBER, CC
LOPEZTALAVERA, JC
GROSZMANN, RJ
机构
[1] W HAVEN VET AFFAIRS MED CTR,HEPAT HEMODYNAM LAB 111J,950 CAMPBELL AVE,W HAVEN,CT 06516
[2] YALE UNIV,SCH MED,NEW HAVEN,CT 06510
关键词
D O I
10.1016/0016-5085(93)90655-V
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The locally acting vasodilator nitric oxide has recently been implicated as a possible mediator in the vasodilatation observed in prehepatic portal hypertension. The aim of this study was to assess if nitric oxide could also be implicated in the vasodilation observed in experimental cirrhosis. Methods: In an in vitro preparation, the vascular responsiveness to potassium chloride of Krebs'-perfused superior mesenteric arterial vascular beds of control (n = 12) and cirrhotic (n = 10) rats with ascites, induced by CCl4, were tested. Results: Increases in perfusion pressures over baseline in response to potassium chloride (125 mmol/L) were significantly lower in vessel preparations of cirrhotic rats (84.7 ± 12.3 and 134.2 ± 16.3 mm Hg for cirrhotic and control rats, respectively, P < 0.05). This hyporeactivity was overcome by incubating the same vessel preparations with the stereospecific nitric oxide biosynthesis antagonist Nω-nitro-l-arginine (10-4 mol/L). The corresponding increases in perfusion pressures were 145.1 ± 18.0 and 173.0 ± 14.8 mm Hg for cirrhotic and control rats, respectively (P = NS). Nitric oxide formation blockade increased the vascular response to KCl in cirrhotic and control rats, the respective percentage changes being 84.6% ± 14.8% and 38.5% ± 12.1% (P < 0.05). Conclusions: (1) Superior mesenteric arterial vascular beds of cirrhotic rats express a significant contracting hyporeactivity to KCl and (2) nitric oxide at least partly mediates the hyporesponsiveness in this in vitro preparation. © 1993.
引用
收藏
页码:1750 / 1754
页数:5
相关论文
共 50 条
  • [21] The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites
    Angeli, P
    Fernández-Varo, G
    Dalla Libera, V
    Fasolato, S
    Galioto, A
    Arroyo, V
    Sticca, A
    Guarda, S
    Gatta, A
    Jiménez, W
    LIVER INTERNATIONAL, 2005, 25 (02) : 429 - 437
  • [22] ARTERIOLAR VASODILATATION IN THE CIRRHOTIC CONSCIOUS RAT - A ROLE FOR NITRIC-OXIDE
    DONI, MG
    PADOIN, E
    RESIDORI, O
    MUTINELLI, F
    JOURNAL OF PHYSIOLOGY-LONDON, 1995, 487P : P168 - P169
  • [23] Splanchnic vascular hyporeactivity in human cirrhosis is related to disease severity and mediated by nitric oxide and carbon monoxide
    Harry, R
    Grieve, D
    Bowles, M
    Heaton, N
    Muiesan, P
    Rela, M
    Wendon, J
    Shah, A
    GASTROENTEROLOGY, 2002, 122 (04) : A665 - A665
  • [24] Splanchnic vascular hyporeactivity in human cirrhosis is related to disease severity and mediated by nitric oxide and carbon monoxide
    Harry, R
    Grieve, D
    Bowles, M
    Heaton, N
    Muiesan, P
    Rela, M
    Wendon, J
    Shah, A
    GUT, 2002, 50 : A32 - A32
  • [25] Vascular hyporesponsiveness in aortic rings from cirrhotic rats: Role of nitric oxide and endothelium
    Ortiz, MC
    Fortepiani, LA
    Martinez, C
    Atucha, NM
    GarciaEstan, J
    CLINICAL SCIENCE, 1996, 91 (06) : 733 - 738
  • [26] ROLE OF NITRIC-OXIDE AND NITRIC-OXIDE CONTAINING COMPOUNDS IN ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION
    MYERS, PR
    GUERRA, R
    HARRISON, DG
    CLINICAL RESEARCH, 1988, 36 (06): : A825 - A825
  • [27] HEMODYNAMIC-EFFECTS OF ENDOGENOUS NITRIC-OXIDE INHIBITION IN CIRRHOTIC RATS
    PIZCUETA, P
    PIQUE, JM
    BOSCH, J
    WHITTLE, BJR
    MONCADA, S
    RODES, J
    HEPATOLOGY, 1991, 14 (04) : A123 - A123
  • [28] HEMODYNAMIC-EFFECTS OF CHRONIC NITRIC-OXIDE INHIBITION IN CIRRHOTIC RATS
    PAK, JM
    ZHANG, Y
    MA, Z
    LEE, SS
    HEPATOLOGY, 1994, 20 (04) : A98 - A98
  • [29] NITRIC-OXIDE SYNTHASE LEVELS IN PORTAL-HYPERTENSIVE AND CIRRHOTIC RATS
    KANWAR, S
    KUBES, P
    TEPPERMAN, BL
    LEE, SS
    HEPATOLOGY, 1994, 20 (04) : A98 - A98
  • [30] ACTIVATION OF THE L-ARGININE NITRIC-OXIDE PATHWAY IS INVOLVED IN VASCULAR HYPOREACTIVITY INDUCED BY ENDOTOXIN
    JULOUSCHAEFFER, G
    GRAY, GA
    FLEMING, I
    SCHOTT, C
    PARRATT, JR
    STOCLET, JC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S207 - S212